ESR1 and obesity due to melanocortin 4 receptor deficiency: In addition, it is worth noting that although the association of obesity with an increased risk of ER+ breast cancer could reflect dysregulation of the endogenous ER pathway, it could instead represent a manifestation of luminal breast cancers, which in humans are typically ER+.